Skip to main content

Table 3 The correlation of the change of TGF-β1 expression before and after treatment with clinical efficacy

From: Evaluation of the immune factors in the tumor environment before and after the treatment of cetuximab combined with chemotherapy

Change of expression

Clinical efficacy

Summary

Invalid

Clinically beneficial

Decrease

0

1

1

Stable

0

5

5

Increase

4

2

6

Summary

4

8

12

  1. PD, SD, PR and CR were transformed to two categorical variables (invalid (defined as 0, including PD) and clinically beneficial (defined as 1, including SD, PR, and CR)).
  2. The number of patients was calculated.